Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc

Código QR

Optimizing management of treatment-na&iuml;ve and treatment-experienced HIV+ patients: the role of maraviroc

Eva Poveda, Vincent SorianoDepartment of Infectious Diseases, Hospital Carlos III, Madrid, SpainAbstract: Maraviroc is the first CCR5 antagonist approved for the treatment of HIV-1 infection. It specifically inhibits the replication of R5 viruses by blocking viral entry. HIV-1 tropism can be estimat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Eva Poveda, Vincent Soriano
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/d00e38efa01d416dbaedef85485721bf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
por: Thore Lorenzen
Publicado: (2010)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen O, et al.
Publicado: (2013)

Magnitude of cytopenias among HIV‑infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART‑experienced children
por: Tsegay YG, et al.
Publicado: (2017)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu S, et al.
Publicado: (2013)

Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir
por: D&#39;Ambrosio R, et al.
Publicado: (2012)

Profile of darunavir in the management of treatment-experienced HIV patients
por: Cameron Wolfe, et al.
Publicado: (2009)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
por: Osterholzer D
Publicado: (2013)

The effectiveness of pictogram intervention in the identification and reporting of adverse drug reactions in naïve HIV patients in Ethiopia: a cross-sectional study
por: Gebreyohannes EA, et al.
Publicado: (2019)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
por: Michael A Horberg, et al.
Publicado: (2010)

Nontyphoidal Salmonella bacteremia in antiretroviral therapy-naïve HIV-infected individuals at three public hospitals in Eastern Ethiopia: prevalence, antimicrobial susceptibility patterns, and associated factors
por: Mitiku H, et al.
Publicado: (2019)

Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1
por: Rolando M Viani
Publicado: (2010)

The use of preexposure treatments for HIV prophylaxis
por: Majid A, et al.
Publicado: (2012)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
por: Pandey KK
Publicado: (2014)

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
por: Patel TS, et al.
Publicado: (2013)

Long-term treatment of patients with HIV-1: the role of atazanavir
por: Miguel &Aacute;ngel Artacho, et al.
Publicado: (2010)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
por: Beatriz Larru Martinez, et al.
Publicado: (2010)

Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
por: Pullen SD, et al.
Publicado: (2014)

Mucoadhesive Microspheres of Maraviroc and Tenofovir Designed for Pre-Exposure Prophylaxis of HIV-1: An in vitro Assessment of the Effect on Vaginal Lactic Acid Bacteria Microflora
por: Ekama SO, et al.
Publicado: (2021)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
por: Seddon J, et al.
Publicado: (2011)

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
por: Enriquez M, et al.
Publicado: (2011)

Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
por: Zhou DT, et al.
Publicado: (2015)

Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions
por: Lidia Elfstrand, et al.
Publicado: (2010)

Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
por: Pefura Yone EW, et al.
Publicado: (2012)

Evaluating the McDonald&#39;s business model for HIV prevention among truckers to improve program coverage and service utilization in India, 2004&ndash;2010
por: Tirumalasetti Rao V, et al.
Publicado: (2013)

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
por: Jose A Vazquez
Publicado: (2010)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018)

New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel N, et al.
Publicado: (2012)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq G, et al.
Publicado: (2018)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora FJ, et al.
Publicado: (2019)

Biologic treatments in Behçet’s disease
por: Fatma Alibaz-Öner, et al.
Publicado: (2021)

Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning &ndash; anxiety, depression, quality of life
por: Maureen E Lyon, et al.
Publicado: (2010)

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
por: Alana MacDonald, et al.
Publicado: (2021)

Perceptions of alcohol use in the context of HIV treatment: a qualitative study
por: Madhombiro M, et al.
Publicado: (2018)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
por: Sicong Li, et al.
Publicado: (2021)

Effect of once-daily FDC treatment era on initiation of cART
por: David M Mosen, et al.
Publicado: (2010)

Sexual behaviors and associated factors among antiretroviral treatment attendees in Ethiopia
por: Demissie K, et al.
Publicado: (2015)

Assessing the HIV rapid test in the fight against the HIV/AIDS epidemic in Trinidad
por: Mungrue K, et al.
Publicado: (2013)

HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites
por: Nitin K Saksena, et al.
Publicado: (2010)

Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
por: Luiz Felipe Domingues Passero, et al.
Publicado: (2021)

Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
por: Crutchley RD, et al.
Publicado: (2016)